Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor

详细信息    查看全文

• 作者：Axel Gossmann ; Thomas H. Helbich ; Sam Mesiano ; David M. Shames ; Michael F. Wendl ; Timothy P. L. Roberts ; Napleone Ferrara ; Robert B. Jaffe ; Robert C. Brasch
• 刊名：American Journal of Obstetrics and Gynecology
• 出版年：2000
• 出版时间：October 2000
• 年：2000
• 卷：183
• 期：4
• 页码：956-963
• 全文大小：112 K

文摘

Objective: Magnetic resonance imaging enhanced with macromolecular contrast medium was used to monitor effects of angiogenesis inhibition on tumor microvascular permeability and ascites volume in an athymic rat model of human ovarian cancer. Study Design: Groups of 6 athymic rats implanted intraperitoneally with SKOV-3, a human ovarian cancer cell line, were treated through a 14-day course with antibody to vascular endothelial growth factor or with saline solution for control animals. Dynamic magnetic resonance imaging was performed with a 92,000-d contrast agent, albumin-(gadolinium-diethylenetriaminepentaacetic acid)₃₀. Vascular permeability was estimated from dynamic enhancement data that were analyzed with a unidirectional 2-compartment kinetic model. Results: Animals treated with vascular endothelial growth factor antibody accumulated significantly smaller volumes of peritoneal ascites (P < .05) and showed significantly lower magnetic resonance imaging–assayed tumor microvascular permeabilities (P < .05) than did control animals. Conclusion: Magnetic resonance imaging enhanced with a macromolecular contrast agent in an athymic rat model of human ovarian cancer treated with anti–vascular endothelial growth factor antibody can be used to measure a reduction in tumor microvascular permeability, corresponding to a reduction in ascites production. (Am J Obstet Gynecol 2000;183:956-63.)